The benzothiazole-thiazole conjugates 4, 5, 6, 7a-c, and 8 were synthesized by introducing a thiazole moiety into the precursor 2-acetamido-6-(2-cyanoacetyl)benzothiazole (3), using a different synthetic method. The structures of these conjugates were determined using FT-IR, 1H/13C NMR, and mass spectral tools. The density functional theory (DFT) modeling of the synthesized hybrids disclosed that all have an angular configuration except for parent 3, who was flat. They presented low frontier molecular orbitals (FMO’s) gap (ΔEH-L), 3.23–4.60 eV, wherein the hybrids 7b and 3 have the least and most values. Meanwhile, the novel conjugates’ antibacterial effectiveness was tested against several pathogenic microorganisms, as well as Gram (+ve), Gram (−ve), and fungal strains. Conjugates 7a-c presented significant antimicrobial effectiveness against Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). However, the synthesized conjugates were evaluated as inhibitors of DNA gyrase, an enzyme critical for bacterial DNA replication. Also, molecular docking simulations were performed for the synthesized conjugates towards PDB: 2XCT, PDB: 1 s14, and PDB: 5tz1 proteins. Both conjugates (7a and 7b) displayed higher binding scores and stable molecular interactions. Moreover, the physicochemical profiles and predicted bioavailability of the newly synthesized benzothiazole-thiazole conjugates were predicted by the SwissADME tools. The study revealed that conjugates 5 and 8 demonstrate the most favorable pharmacokinetic properties and bioavailability scores, making them prime candidates for further pharmaceutical development.
Read full abstract